Single and Multiple Dose Safety, Tolerability and Pharmacokinetics of the Selective M1 Receptor Partial Agonist HTL0018318 in Healthy Volunteers

被引：0

作者：

Nathan, Pradeep ^{[1
]}

Liptrot, Jan ^{[1
]}

Bakker, Charlotte ^{[1
]}

'tHart, Ellen ^{[1
]}

Klaassen, Erica ^{[1
]}

Prins, Samantha ^{[1
]}

van der Doef, Thalia ^{[1
]}

Walker, Mike ^{[1
]}

Brown, Giles ^{[1
]}

Brown, Alastair ^{[1
]}

Congreve, Miles ^{[1
]}

Weir, Malcolm ^{[1
]}

Marshall, Fiona ^{[1
]}

Cross, David ^{[1
]}

Groeneveld, Geert Jan ^{[1
]}

Tasker, Tim ^{[1
]}

机构：

[1] Sosei Heptares, Cambridge, England

来源：

NEUROPSYCHOPHARMACOLOGY | 2018年 / 43卷

关键词：

M1 and M4 Muscarinic Receptors; Phase; 1; Safety; Pharmacokinetics; Dementia;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

W51

引用

页码：S408 / S409

页数：2

共 50 条

[41] Results from the Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers
Gurov, Xiaoshu Dai
Merica, Elizabeth
Iyer, Varsha
Claeys, Annie
Patil, Spurthi
Urbstonaitis, Rolandas
Xiao, James
Callaghan, Michael U.
BLOOD, 2022, 140 : 5426 - 5427
[42] ACP-103, a 5-HT2A receptor inverse agonist: Safety, tolerability, and pharmacokinetics in healthy volunteers
Vanover, KE
Weiner, DM
Schlienger, N
Thygesen, M
Tolf, B
Hacksell, U
Brann, MR
Davis, RE
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S253 - S253
[43] SAFETY, TOLERABILITY AND PHARMACOKINETICS OF ADL5859, A NOVEL DELTA OPIOID RECEPTOR AGONIST (DORA), IN HEALTHY HUMAN VOLUNTEERS
Leese, P.
Schomer, D.
Berger, B.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S41 - S41
[44] Seletracetam (UCB 44212): Single and multiple rising dose safety, tolerability and pharmacokinetics in healthy subjects
Leese, P. T.
Goldwater, D. R.
Hulhoven, R.
Salas, E.
Toublanc, N.
Chen, D.
Sargentini-Maier, M. L.
Stockis, A.
EPILEPSIA, 2006, 47 : 164 - 164
[45] Single- and Multiple-Dose Pharmacokinetics, Safety and Tolerability of Lurasidone in Healthy Chinese Subjects
Chaoying Hu
Yijun Wang
Rong Song
Chen Yu
Xiaoyan Luo
Jingying Jia
Clinical Drug Investigation, 2017, 37 : 861 - 871
[46] Single- and Multiple-Dose Pharmacokinetics, Safety and Tolerability of Lurasidone in Healthy Chinese Subjects
Hu, Chaoying
Wang, Yijun
Song, Rong
Yu, Chen
Luo, Xiaoyan
Jia, Jingying
CLINICAL DRUG INVESTIGATION, 2017, 37 (09) : 861 - 871
[47] OCE-205, A Novel, Selective Vasopressin Receptor Mixed Agonist-Antagonist: Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics from a Phase 1 Study in Healthy Volunteers
Bagger, Yu
Ravis, William R.
Harris, Geoff
Bukofzer, Stan
CLINICAL DRUG INVESTIGATION, 2023, 43 (09) : 709 - 717
[48] OCE-205, A Novel, Selective Vasopressin Receptor Mixed Agonist-Antagonist: Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics from a Phase 1 Study in Healthy Volunteers
Yu Bagger
William R. Ravis
Geoff Harris
Stan Bukofzer
Clinical Drug Investigation, 2023, 43 : 709 - 717
[49] Pharmacokinetics of cytisine, an 42 nicotinic receptor partial agonist, in healthy smokers following a single dose
Jeong, Soo Hee
Newcombe, David
Sheridan, Janie
Tingle, Malcolm
DRUG TESTING AND ANALYSIS, 2015, 7 (06) : 475 - 482
[50] Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers
Wenzler, E.
Ellis-Grosse, E. J.
Rodvold, K. A.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (09)

← 1 2 3 4 5 →